Houlihan Lokey, Inc. HLI
129.07
1.58
1.24%
as of 25 Sep
- Market cap
- $8.9B
- P/E
- 21.2×
Follow HLI
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
22.02 | 22.48 | 25.88 | 31.93 |
+8 more quarters Free account |
P/S ratio |
3.53 | 3.65 | 4.38 | 5.36 | |
P/FCF ratio |
18.40 | 14.02 | 15.71 | 17.55 | |
P/Operating CF |
(26.55) | 32.62 | 53.32 | 42.25 | |
P/B ratio |
3.96 | 4.08 | 5.06 | 6.12 | |
Price to Tangible BV |
13.60 | 12.88 | 14.48 | 18.24 | |
EV/Sales |
3.40 | 3.35 | 4.14 | 5.16 | |
EV/EBITDA |
15.61 | 15.40 | 18.47 | 23.22 | |
EV/Operating CF |
17.16 | 12.46 | 14.24 | 16.19 | |
EV/FCF |
17.70 | 12.87 | 14.83 | 16.89 | |
Quick Ratio |
1.36 | 1.17 | 1.28 | 1.26 | |
Current Ratio |
1.36 | 1.17 | 1.28 | 1.26 | |
Net Debt/EBITDA |
(8.66) | (8.94) | (6.25) | (5.71) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.70 | 0.64 | 0.71 | 0.73 | |
Operating CF/Net income |
(4.31) | 2.95 | 1.87 | 2.91 | |
Capex/Depreciation |
(0.75) | (0.78) | (0.08) | (0.24) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.43 | 0.37 | 0.38 | 0.39 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.06) | (0.06) | (0.03) | (0.03) | |
Graham Number |
68.17 | 71.13 | 72.20 | 69.67 | |
Earnings Yield |
4.54% | 4.45% | 3.86% | 3.13% | |
Free Cash Flow Yield |
5.44% | 7.13% | 6.37% | 5.70% | |
Revenue per Share |
7.68 | 9.56 | 10.76 | 9.85 | |
Operating CF per Share |
(5.05) | 4.40 | 3.27 | 4.86 | |
Capex per Share |
(0.09) | (0.09) | (0.01) | (0.04) | |
Free Cash Flow per Share |
(5.14) | 4.31 | 3.26 | 4.82 | |
Cash per Share |
11.20 | 17.87 | 15.86 | 13.79 | |
Shareholders Equity per Share |
33.91 | 35.19 | 34.42 | 33.55 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
33.91 | 35.19 | 34.42 | 33.55 | |
Free Cash Flow |
(342.00) | 286.78 | 217.04 | 322.99 | |
Working Capital |
258.00 | 204.00 | 278.57 | 243.11 | |
Capital Expenditures |
(6.00) | (6.25) | (0.64) | (2.42) | |
Net Current Asset Value |
(493.00) | (550.00) | (375.63) | (371.74) | |
EV/EBIT |
16.66 | 16.65 | 20.17 | 25.52 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 | |
Net Profit Margin |
15.26% | 15.62% | 16.25% | 16.95% | |
Price to Operating Income |
17.32 | 18.14 | 21.37 | 26.52 | |
| Other line items | |||||
Average Receivables |
222.32 | 242.66 | 188.78 | 246.06 | |
Average Payables |
113.80 | 136.61 | 115.39 | 106.76 | |
Average Assets |
3,617.40 | 4,064.35 | 3,706.26 | 3,503.06 | |
Average Common Equity |
2,216.41 | 2,258.44 | 2,187.15 | 2,101.99 |
Columns are period end dates